Back to search

University of Ioannina

Στοχευμένα φάρμακα: ενδοκυττάρωση, διακίνηση και μοριακός μηχανισμός δράσης: ταυτοποίηση και λειτουργικός χαρακτηρισμός ρυθμιστών της αγγειογένεσης σε καρκινικά κύτταρα του παχέος εντέρου που φέρουν μεταλλάξεις στο γονίδιο PIK3CA

Abstract

dc:description

The deregulation of the PI3K signaling pathway by several mechanisms has a crucial role in colon cancer progression. In 10-30% of colon cancers the oncogene PIK3CA, which encodes the catalytic subunit of PI3Ks (p110α), is mutated and has been studied as an effective molecular target for therapeutic interventions. The most common mutations of the PIK3CA gene in colon cancer are H1047R, in the kinase domain, and E545K, in the helical domain, both of which lead to oncogenic transformation by increasing PI3K activity. The overactivation of PI3K by these mutations regulates growth, survival and also angiogenesis. In the present study, in order to investigate regulators of angiogenesis downstream of PIK3CA the colorectal cancer cell lines DLD1 and HCT116 were used in which the most common mutations of PI3KCA, E545 and H1047R respectively, were inactivated bygene targeting generating isogenic cell lines harbouring either the wild type (WT) or the mutated allele (MUT). We first validated the genotype of the cell lines using a genotyping strategy designed to ensure that the cell lines are correct. We also tested whether the cell lines behave as expected regarding the phosphorylation of AKT on both T308, S473. Microarray analysis of WT and MUT clones in 0.5% serum yeilded 34 differentially regulated genes (18 upregulated, 16 downregulated) in HCT116 cells and 47 genes in DLD1 cells (25 upregulated, 22 downregulated) among which 2 genes were common. Furthermore, the microarray results yielded some candidate genes which, according to the literature, may play a role in angiogenesis. One of the most important genesupregulated in DLD1 MUT cell line is the Chemokine (C-X-C motif) ligand 5 (CXCL5). CXCL5 is a low molecular weight chemotactic chemokine, which binds the G-protein coupled receptor CXCR2 and acts as a proangiogenic agent and a powerful attractant for neutrophils. The levels of secreted CXCL5 by DLD1 MUT cells showed a 3-fold increase compared to DLD1 WT by Western Blot. Also, using a series of AKT1, AKT2 and AKT1/2 knockout DLD1 clones, we demonstrated that the expression of CXCL5 is AKT1 and not AKT2 dependent. To further investigate the effects of CXCL5 in DLD1-MUT cells and in angiogenic responses, in vitro and in vivo, two CXCL5 knockout clones (DLD1-MUT-CXCL5-/-CL7 and DLD1-MUT-CXCL5-/-CL8) of DLD1-MUT cells were generated using the CRISPR/Cas9 Double nickase system. Live cell analysis experiments using the IncuCyte system showed that DLD1-MUT- CXCL5-/- cells exhibit reduced growth and invasion (through Matrigel) compared to DLD1-MUT cells. Also, DLD1-MUT- CXCL5-/- clones showed decreased tumorsphere forming ability in vitro compared to the DLD1-MUT cells, indicating a role of CXCL5 in the regulation of DLD1-MUT cell stemness. Additionally, it was observed that CXCL5 modulates proliferation and tube formation of HUVEC cells in vitro. In vivo experiments were performed by incorporating either DLD1 MUT CXCL5-/- or DLD1 MUT cells into Matrigel plugs. The plugs were injected subcutaneously in mice and tumor volume and angiogenesis was scored. DLD1-MUT-CXCL5-/- cell plugs generated smaller tumors and decreased percentage of CD31 positive vessels with apparent lumen compared to plugs containing DLD1-MUT cells. In conclusion, in this study we show that PIK3CA E545K results in enhanced expression of CXCL5 in an AKT1 dependent manner in DLD1 human colon cancer cells. We also provide evidence that CXCL5 is implicated in tumor proliferation, invasion and angiogenesis.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kougioumtzi, Anastasia
  • Κουγιουμτζή, Αναστασία

Subjects

dc:subject × 26

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/46228

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kougioumtzi, Anastasia; Κουγιουμτζή, Αναστασία. Στοχευμένα φάρμακα: ενδοκυττάρωση, διακίνηση και μοριακός μηχανισμός δράσης: ταυτοποίηση και λειτουργικός χαρακτηρισμός ρυθμιστών της αγγειογένεσης σε καρκινικά κύτταρα του παχέος εντέρου που φέρουν μεταλλάξεις στο γονίδιο PIK3CA. University of Ioannina, 2018. http://hdl.handle.net/10442/hedi/46228